The Journal of Urology
Volume 179, Issue 2 , Pages 770-774 , February 2008

Mechanisms by Which a Phytotherapeutic Drug Influences Bladder Activity in Rats

Received 2 June 2007

References 

  1. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet. 1991;338:469
  2. McVary KT, Rademaker A, Lloyd GL, Gann P. Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2005;174:1327
  3. Sugaya K, Kadekawa K, Ikehara A, Nakayama T, Gakiya M, Nashiro F, et al. Influence of hypertension on lower urinary tract symptoms in benign prostatic hyperplasia. Int J Urol. 2003;10:569
  4. Chapple CR. Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician. BJU Int. 2004;94:738
  5. Ishihama H, Momota Y, Yanase H, Wang X, de Groat WC, Kawatani M. Activation of alpha1D adrenergic receptors in the rat urothelium facilitates the micturition reflex. J Urol. 2006;175:358
  6. Bales GT, Christiano AP, Kirsh EJ, Gerber GS. Phytotherapeutic agents in the treatment of lower urinary tract symptoms: a demographic analysis of awareness and use at the University of Chicago. Urology. 1999;54:86
  7. Song Y, Li NC, Wang XF, Ma LL, Wan B, Hong BF, et al. Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia. Zhonghua Nan Ke Xue. 2005;11:674
  8. Nishijima S, Sugaya K, Miyazato M, Ogawa Y. Effect of Gosha-jinki-gan, a blended herbal medicine, on bladder activity in rats. J Urol. 2007;177:762
  9. Kinoshita H, Kawamura N, Miyakita H, Tanaka M, Watanabe S, Onda H, et al. The effects of combination therapy using Eviprostat® and tamsulosin hydrochloride (Harnal®) for benign prostatic hyperplasia. Hinyouki Geka. 1998;11:1297
  10. Ishigooka M, Hashimoto T, Hayami S, Tomaru M, Nakada T, Mitobe K. Clinical and retrospective evaluation of Eviprostat: a non-hormonal and non-neuropharmacological agent for benign prostatic hyperplasia. Int Urol Nephrol. 1995;27:61
  11. Ishigami J, Kodama H, Sato K. Clinical use of eviprostat for prostatic hypertrophy. Dermatol Urol. 1966;28:474
  12. Boyle P, Robertson C, Lowe F, Roehrborn C. Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia. BJU Int. 2004;93:751
  13. Debruyne F, Koch G, Boyle P, Da Silva FC, Gillenwater JG, Hamdy FC, et al. Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study. Eur Urol. 2002;41:497
  14. Sugaya K, Nishijima S, Miyazato M, Chinen Y, Morozumi M, Ogawa Y. Intravenous noradrenalin facilitates afferent activity of the micturition reflex at the lumbosacral cord in rats. 2004;Presented at annual meeting of the International Continence Society, Paris, France, August 25–27
  15. Gillespie JI. Noradrenaline inhibited autonomous activity in the isolated guinea pig bladder. BJU Int. 2004;93:401
  16. Andersson KE, Yoshida M. Antimuscarinics and the overactive detrusor: which is the main mechanism of action?. Eur Urol. 2006;43:1
  17. Yoshida M, Inadome A, Murakami S, Miyamae K, Iwashita H, Otani M, et al. Effects of age and muscle stretching on acetylcholine release in isolated human bladder smooth muscles. J Urol. 2002;167(suppl):40;abstract 160.
  18. Sun Y, Keay S, De Deyne PG, Chai TC. Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis. J Urol. 2001;166:1951
  19. Sherer TB, Spitsbergen JM, Steers WD, Tuttle JB. Thrombin regulates nerve growth factor secretion from vascular, but not bladder smooth muscle cells. Cell Tissue Res. 1997;289:155
  20. Oka M, Tachibana M, Noda K, Inoue N, Tanaka M, Kuwabara K. Relevance of anti-reactive oxygen species activity to anti-inflammatory activity of components of Eviprostat®, a phytotherapeutic agent for benign prostatic hyperplasia. Phytomedicine. 2007;14:465

PII: S0022-5347(07)02494-9

doi: 10.1016/j.juro.2007.09.023

The Journal of Urology
Volume 179, Issue 2 , Pages 770-774 , February 2008

Article Tools

* Image Usage & Resolution